Cofoe Medical Technology301087.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 19, 2026, Cofoe Medical Technology (301087.SZ) trades at a P/E of 29.30x, P/B of 2.16x, P/S of 2.87x, and a dividend yield of 3.29%.
Longitudinal percentile comparison: P/E sits at the 69th percentile over the trailing 10Y window (vs. 61st percentile over 3Y); P/B sits at the 74th percentile over the trailing 10Y window (vs. 70th percentile over 3Y); P/S sits at the 57th percentile over the trailing 10Y window (vs. 74th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 40th percentile within its industry and the 41st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 3.29%, ranking at the 49th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 4.8 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Cofoe Medical Technology operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 301087 · SZSE: 301087 · 301087
Want the full picture on whether Cofoe Medical Technology (301087.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 29.30 | ||||||
| P/B (MRQ) | 2.16 | ||||||
| P/S (TTM) | 2.87 | ||||||
| Dividend Yield | 3.29% | ||||||
| Buyback + Div Yield | 3.29% |